Christophe Dooms - Concepedia

Author

Christophe Dooms

Also Known As

C Dooms, C. Dooms, Christophe Dooms, DOOMS C, Dooms C, Dooms, C., Dooms, Christophe, Eric Lim, Kristiaan Nackaerts, Thoracoscopy

321

Publications

11.5K

Citations

H-Index

106

Concepts

All Affiliations

KU Leuven The Netherlands Cancer Institute Universitair Ziekenhuis Leuven Institut Gustave Roussy Ghent University Hospital

About

Christophe Dooms is an author at KU Leuven specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	39	3.7K
2	Health Sciences	14	16	1.9K
3	Engineering	2	2	94
4	Public Health	2	2	101
5	Allergy	1	1	22

Christophe Dooms

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer Heather A. Wakelee, Moïshe Liberman, Terufumi Kato, New England Journal of Medicine	2023	903
Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer Paul De Leyn, Christophe Dooms, Didier Lardinois, European Journal of Cardio-Thoracic Surgery	2014	803
Mediastinoscopy vs Endosonography for Mediastinal Nodal Staging of Lung Cancer Jouke T. Annema, Jan P. van Meerbeeck, Robert C. Rintoul, JAMA	2010	606
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial Adrianus J. de Langen, Melissa L. Johnson, Julien Mazières, The Lancet Non-small-cell Lung CancerMedicinePathologyCancer TreatmentCancer Genetics	2023	507
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up Johan Vansteenkiste, Lucio Crinò, Christophe Dooms, Annals of Oncology Advanced Lung DiseaseMedicineCancer ManagementEsmo Consensus ConferencePulmonary Blastoma	2014	492
Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages Els Wauters, Pierre Van Mol, Abhishek D. Garg, Cell Research	2021	372
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer K.M. Kerr, L. Bubendorf, Martin J. Edelman, Annals of Oncology Molecular BiomarkersPrognostic BiomarkersOncologyNon-small-cell Lung CancerMedicine	2014	286
Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report Anne‐Marie C. Dingemans, Lizza Hendriks, Thierry Berghmans, Journal of Thoracic Oncology	2019	281
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity Lore Vanderbeke, Pierre Van Mol, Yannick Van Herck, Nature Communications	2021	255
The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer Angela van Baardwijk, Christophe Dooms, Robert Jan van Suylen, European Journal of Cancer Positron Emission TomographyOncologic ImagingMedicineMaximum UptakeLung Cancer	2007	194

Page 1